2.06
XORTX Therapeutics Inc.
Metrics score locked — part of Premium
FY20
FY21
FY23
FY24
FY25
FY20 – FY25
Assets
(positive)
Change from FY20 to FY25
FY20:
FY21:
20.2
FY23:
4.07
FY24:
2.68
FY25:
1.26
(positive)
Change from FY20 to FY25
FY20:
0.23
FY21:
1.86
FY23:
1.40
FY24:
1.42
FY25:
1.42
Total assets
Change from FY20 to FY25
FY20:
2.29
FY21:
22.0
FY23:
5.47
FY24:
4.09
FY25:
2.68
Liabilities & Equity
(negative)
Change from FY20 to FY25
FY20:
1.03
FY21:
0.70
FY23:
0.29
FY24:
0.76
FY25:
0.60
(negative)
FY20:
0
FY21:
4.60
FY23:
0.53
FY24:
0
FY25:
0
(positive)
Change from FY20 to FY25
FY20:
1.26
FY21:
16.7
FY23:
4.64
FY24:
3.34
FY25:
2.08
Total liabilities & equity
Change from FY20 to FY25
FY20:
2.29
FY21:
22.0
FY23:
5.47
FY24:
4.09
FY25:
2.68